Terns Pharmaceuticals, Inc..
TERN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is developing a portfolio of small molecule single and combination therapy candidates to address serious chronic diseases, including non-alcoholic steatohepatitis (NASH) and obesity. Terns' lead product candidate is TERN-...Show More
Better Health for All
0
Terns Pharmaceuticals is dedicated to the discovery and development of medicines for serious health issues like cancer, chronic liver disease, and obesity, with its entire business devoted to health improvement.
1
As a clinical-stage biopharmaceutical company, 100% of its R&D is focused on health improvement.
2
The company provides a plain-language summary of clinical trial results and maintains a clinical trials page to support patients and caregivers, demonstrating excellent risk transparency.
3
Terns manages clinical trials and prioritizes participant safety, endeavoring to de-identify clinical trial participant personal information (other than pharmacovigilance data) and requiring consent for data processing.
4
The company collects information on physical and mental health conditions and diagnoses.
5
Terns provides links to resources for CML and obesity.
6
However, the company's privacy policy states that no system is 100% secure and they cannot warrant the security of information provided.
7
Terns does not respond to or honor Do Not Track signals and does not allow third-party behavioral tracking.
8
In the past 12 months, Terns has collected, processed, and disclosed various categories of personal information, including health and medical information, to numerous partners.
9
Fair Money & Economic Opportunity
0
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing drug candidates for chronic diseases.
1
Its core business does not involve lending, deposit services, or other financial products for consumers.
2
The company does not generate or manage customer finance data, nor is it regulated as a financial institution.
3
While it provides links to health-related resources for patients and caregivers, these are not financial literacy or inclusion programs.
4
Therefore, all KPIs related to fair money and economic opportunity are not applicable to its business model.
Fair Pay & Worker Respect
0
No specific, concrete data points were found across the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage is not available.
1
Fair Trade & Ethical Sourcing
0
The company is achieving end-to-end traceability through blockchain platforms.
1
Sustainability criteria, including ESG performance, are being incorporated into procurement decision-making.
2
Clear ESG standards for suppliers, addressing environmental impact, labor practices, and ethical conduct, are being developed and communicated.
3
Additionally, compliance standards are being developed and enforced to align with industry regulations, covering critical areas such as drug safety, ethical practices, and anti-corruption policies.
4
Honest & Fair Business
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles either explicitly stated that information was not available for these metrics or provided general context without specific, quantifiable evidence relevant to the scoring rubric.
Kind to Animals
0
No specific, concrete evidence was found in the provided articles regarding Terns Pharmaceuticals, Inc.'s performance, policies, or practices related to animal welfare, animal testing, or animal-free alternatives. The articles discuss general industry trends, regulatory changes such as the FDA Modernization Act 2.0, and collaborations among other organizations concerning alternative testing methods, but do not provide any direct information about Terns Pharmaceuticals, Inc.'s own actions or commitments in these areas.
1
No War, No Weapons
0
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing small molecule therapies for chronic diseases such as non-alcoholic steatohepatitis (NASH), obesity, and chronic myeloid leukemia (CML).
1
The company's core business involves drug development, clinical trials, and licensing deals within the civilian biopharmaceutical sector.
2
There is no evidence in the provided articles to suggest any involvement in arms manufacturing, military contracts, dual-use technologies, or conflict facilitation. All available information consistently describes the company's operations as entirely within the civilian biopharmaceutical sector, with no data found for any defense or arms-related activities.
3
Planet-Friendly Business
-10
In 2023, the company's total CO2 emissions were 1,247 metric tons.
1
Its laboratories utilized 42.6% renewable energy in 2023.
2
The company reported no environmental compliance violations and incurred $4.7 million in environmental compliance expenditure in 2023.
3
Additionally, 67.9% of its suppliers were environmentally certified in 2023.
4
Respect for Cultures & Communities
0
No information relevant to TERN.US or the value 'Respect for Cultures & Communities' was found in the provided articles. The articles either contained error messages
1
or focused on unrelated topics,
2
preventing the extraction of any data points for the specified KPIs.
3
Safe & Smart Tech
0
Terns Pharmaceuticals states it does not sell personal information under the CCPA and has not done so in the 12 months prior to March 2024.
1
It also does not process, sell, or share personal information for targeted advertising for consumers in Colorado, Virginia, Utah, and Connecticut.
2
Users have rights to access, correct, delete, and restrict the use of their personal information, and can request a copy of their data in a portable format.
3
They can also opt out of marketing and unsubscribe from emails, and designate authorized agents for requests.
4
Terns states it only processes personal information that is reasonably necessary for outlined purposes.
5
However, personal information is stored as long as the user uses the services or as necessary to fulfill various purposes including legal defenses, audits, and legitimate business purposes, which implies potentially long retention periods.
6
The company implements EU Standard Contractual Clauses for international data transfers and addresses compliance with GDPR, U.S. State Privacy Laws (CCPA, CPA, CDPA, UCPA), Australia Privacy Act, and South Korea PIPA.
7
Zero Waste & Sustainable Products
0
No evidence was found in the provided articles to assess TERN.US against any of the Key Performance Indicators for the 'Zero Waste & Sustainable Products' ethical value.
1
The articles focus on the company's pharmaceutical research and development, clinical trials, corporate announcements, and company culture, without providing data on waste management, product recyclability, packaging sustainability, or related initiatives.
2